| Firm |
Analyst |
| Caris & Company
|
Mario Corso |
| CRT Capital Group
|
Tim Chiang |
| Jefferies & Co.
|
Biren Amin |
| Ladenburg Thalmann & Co.
|
Juan Sanchez |
| Leerink Swann
|
Steve Yoo |
| Maxim Group
|
Yale Jen |
| Oppenheimer & Co.
|
Christopher Holterhoff |
| ThinkEquity LLC
|
James Molloy |
| WJB Capital Group
|
John Newman |
Questcor Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Questcor Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Questcor Pharmaceuticals, Inc. or its management. Questcor Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
